Information About Vaxzevria▼ COVID-19 Vaccine (ChAdOx1-S [recombinant])
Disclaimer: The information on this page is intended for Vaccine Recipients only.
A Conditional Marketing Authorisation has been granted in Great Britain for the product Vaxzevria for active immunisation of individuals aged 18 years and older for the prevention of coronavirus disease 2019 (COVID-19).
As with any new medicine in the UK this product will be closely monitored to allow quick identification of new safety information. You can help by reporting any side effects you may get.